Thermoresponsive polysarcosine-based nanoparticles

Huayang Yu, Nicola Ingram, Jason V. Rowley, Sam Parkinson, David C. Green, Nicholas J. Warren and Paul D. Thornton

J. Mater. Chem. B, 2019, 7, 4217
DOI: 10.1039/C9TB00588A

Site-selective modification strategies in antibody–drug conjugates

Stephen J. Walsh, Jonathan D. Bargh, Friederike M. Dannheim, Abigail R. Hanby, Hikaru Seki, Andrew J. Counsell, Xiaoxu Ou, Elaine Fowler, Nicola Ashman, Yuri Takada, Albert Isidro-Llobet, Jeremy S. Parker, Jason S. Carroll and David R. Spring

Chem. Soc. Rev., 2021, 50, 1305
DOI: 10.1039/D0CS00310G

Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody–drug conjugation

Kanwen Yang, Bo Chen, Diego A. Gianolio, James E. Stefano, Michelle Busch, Charlene Manning, Kim Alving, Richard C. Gregory, William H. Brondyk, Robert J. Miller and Pradeep K. Dhal

Org. Biomol. Chem., 2019, 17, 8115
DOI: 10.1039/C9OB01639B

Synthesis of disulfide-bridging trehalose polymers for antibody and Fab conjugation using a bis-sulfone ATRP initiator

Neil L. Forsythe and Heather D. Maynard

Polym. Chem., 2021, 12, 1217
DOI: 10.1039/D0PY01579B

Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase

Yoan Brissonnet, Guillaume Compain, Brigitte Renoux, Eva-Maria Krammer, Franck Daligault, David Deniaud, Sébastien Papot and Sébastien G. Gouin

RSC Adv., 2019, 9, 40263
DOI: 10.1039/C9RA08847D

A homogeneous high-DAR antibody–drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides

Neelie Zacharias, Vladimir N. Podust, Kimberly K. Kajihara, Douglas Leipold, Geoffrey Del Rosario, Desiree Thayer, Emily Dong, Maciej Paluch, David Fischer, Kai Zheng, Corinna Lei, Jintang He, Carl Ng, Dian Su, Luna Liu, Shabkhaiz Masih, William Sawyer, Jeff Tinianow, Jan Marik, Victor Yip, Guangmin Li, Josefa Chuh, J. Hiroshi Morisaki, Summer Park, Bing Zheng, Hilda Hernandez-Barry, Kelly M. Loyet, Min Xu, Katherine R. Kozak, Gail Lewis Phillips, Ben-Quan Shen, Cong Wu, Keyang Xu, Shang-Fan Yu, Amrita Kamath, Rebecca K. Rowntree, Dorothea Reilly, Thomas Pillow, Andrew Polson, Volker Schellenberger, Wouter L. W. Hazenbos and Jack Sadowsky

Chem. Sci., 2022, 13, 3147
DOI: 10.1039/D1SC05243H

Compact hydrophilic electrophiles enable highly efficacious high DAR ADCs with excellent in vivo PK profile

Philipp Ochtrop, Jahaziel Jahzerah, Paul Machui, Isabelle Mai, Dominik Schumacher, Jonas Helma, Marc-André Kasper and Christian P. R. Hackenberger

Chem. Sci., 2023, 14, 2259
DOI: 10.1039/D2SC05678J

Diazido macrocyclic sulfates as a platform for the synthesis of sequence-defined polymers for antibody drug conjugates

Neil L. Forsythe, Mikayla F. Tan and Heather D. Maynard

Chem. Sci., 2022, 13, 3888
DOI: 10.1039/D1SC06242E

Alteration of Physicochemical Properties for Antibody-Drug Conjugates and Their Impact on Stability

Jakob W. Buecheler, Matthias Winzer, Christian Weber and Henning Gieseler

Journal of Pharmaceutical Sciences, 2020, 109, 161
DOI: 10.1016/j.xphs.2019.08.006

Site-Specific, Stoichiometric-Controlled, PEGylated Conjugates of Fibroblast Growth Factor 2 (FGF2) with Hydrophilic Auristatin Y for Highly Selective Killing of Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1 (FGFR1)

Mateusz Adam Krzyscik, Małgorzata Zakrzewska and Jacek Otlewski

Mol. Pharmaceutics, 2020, 17, 2734
DOI: 10.1021/acs.molpharmaceut.0c00419

Introducing Savie: A Biodegradable Surfactant Enabling Chemo- and Biocatalysis and Related Reactions in Recyclable Water

Joseph R. A. Kincaid, Madison J. Wong, Nnamdi Akporji, Fabrice Gallou, David M. Fialho and Bruce H. Lipshutz

J. Am. Chem. Soc., 2023, 145, 4266
DOI: 10.1021/jacs.2c13444

Engineering precise sequence-defined polymers for advanced functions

Qiangqiang Shi, Zhengyu Deng, Mingxuan Hou, Xianglong Hu and Shiyong Liu

Progress in Polymer Science, 2023, 141, 101677
DOI: 10.1016/j.progpolymsci.2023.101677

High-payload trastuzumab–drug conjugates achieved through hydrophilic Y-shaped pendant PEG linkers for a potent and selective antitumor response

Benedetta Campara, Tommaso Tedeschini, Antonella Grigoletto, Daniela Gabbia, Ilaria Zanotto, Marika Salvalaio, Nouran Said Fathalla Zahran, Yuki Matsuno, Minori Takino, Kota Tange, Yosuke Matsuoka, Sara De Martin and Gianfranco Pasut

International Journal of Biological Macromolecules, 2026, 343, 150375
DOI: 10.1016/j.ijbiomac.2026.150375

Toward Prostate Cancer Early Warning with a Self‐Powered Wearable Biosensing Platform Integrated with Machine Learning

Jing Xu, Hanxiao Chen, Qichen Yuan, Liucun Yin, Yifang Tao, Hong Wang, Yuquan Xue, Delai Fu, Huan Pang, Tie Chong and Li Xue

Advanced Science, 2026
DOI: 10.1002/advs.202524234

Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates

T. Tedeschini, B. Campara, A. Grigoletto, M. Bellini, M. Salvalaio, Y. Matsuno, A. Suzuki, H. Yoshioka and G. Pasut

Journal of Controlled Release, 2021, 337, 431
DOI: 10.1016/j.jconrel.2021.07.041

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance

Nick Evans, Ruslan Grygorash, Paul Williams, Andrew Kyle, Terrence Kantner, Ravindra Pathak, XiaoBo Sheng, Fabio Simoes, Hiteshri Makwana, Ricardo Resende, Elena de Juan, Alan Jenkins, David Morris, Aurelie Michelet, Frances Jewitt, Felicity Rudge, Nicolas Camper, Anaïs Manin, William McDowell, Martin Pabst, Antony Godwin, Mark Frigerio and Matthew Bird

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.764540

Engineering discrete synthetic macromolecules for biomedical applications

Aizong Shen, Lei Zhang, Yanbo Xie, Xueyu Zhu, Jinming Hu and Shiyong Liu

Nano Today, 2023, 48, 101728
DOI: 10.1016/j.nantod.2022.101728

Exploration of the antibody–drug conjugate clinical landscape

Heather Maecker, Vidya Jonnalagadda, Sunil Bhakta, Vasu Jammalamadaka and Jagath R. Junutula

mAbs, 2023, 15
DOI: 10.1080/19420862.2023.2229101

Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement

Mingxia Jiang, Qiao Li and Binghe Xu

Drug Resistance Updates, 2024, 75, 101086
DOI: 10.1016/j.drup.2024.101086

Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?

Baochen Zhang, Mo Wang, Li Sun, Jiawei Liu, Libinghan Yin, Mingjing Xia, Ling Zhang, Xifu Liu and Yu Cheng

J. Med. Chem., 2024, 67, 11469
DOI: 10.1021/acs.jmedchem.4c00106

Glucuronides: From biological waste to bio-nanomedical applications

Pierre-Alain Burnouf, Steve R. Roffler, Chia-Ching Wu and Yu-Cheng Su

Journal of Controlled Release, 2022, 349, 765
DOI: 10.1016/j.jconrel.2022.07.031

Synthesis and Characterization of Dendrimer-Based Polysarcosine Star Polymers: Well-Defined, Versatile Platforms Designed for Drug-Delivery Applications

Richard M. England, Jennifer I. Moss, Anders Gunnarsson, Jeremy S. Parker and Marianne B. Ashford

Biomacromolecules, 2020, 21, 3332
DOI: 10.1021/acs.biomac.0c00768

Synthesis of Novel bis‐Triazolinedione Crosslinked Amphiphilic Polypept(o)ide Nanostructures

Ruairí P. Brannigan, Scott D. Kimmins, Elena Bobbi, Séamus Caulfield and Andreas Heise

Macro Chemistry & Physics, 2019, 220
DOI: 10.1002/macp.201900067

Site-Specific Glycan Conjugation Improves Stability and Efficacy of an Antibody–Drug Conjugates Bearing DXd as a Cytotoxic Payload

Shino Manabe, Shogo Senga, Shogo Iwamoto, Hikaru Yarita, Ryo Takahashi, Ai Mitani, Wataru Sumiyoshi, Asako Hoshinoo, Methanee Hiranyakorn, Takashi Kinoshita and Chihoko Yoshimura

ACS Omega, 2026, 11, 13459
DOI: 10.1021/acsomega.5c10898

Understanding Acid-Promoted Polymerization of the N-Substituted Glycine N-Thiocarboxyanhydride in Polar Solvents

Botuo Zheng, Songyi Xu, Xufeng Ni and Jun Ling

Biomacromolecules, 2021, 22, 1579
DOI: 10.1021/acs.biomac.1c00016

Utility of Triethyloxonium Tetrafluoroborate for Chloride Removal during Sarcosine N‐Carboxyanhydride Synthesis: Improving NCA Purity

Leon Capelôa, Rafael Miravet Martí, Aroa Duro‐Castaño, Vicent J. Nebot and Matthias Barz

Chemistry A European J, 2024, 30
DOI: 10.1002/chem.202304375

Polysarcosine as PEG Alternative for Enhanced Camptothecin-Induced Cancer Immunogenic Cell Death

Xikuang Yao, Changrui Sun, Fei Xiong, Weina Zhang, Wenjing Yao, Yinghui Xu, Wenpei Fan and Fengwei Huo

ACS Appl. Mater. Interfaces, 2024, 16, 19472
DOI: 10.1021/acsami.4c00166

Exo-Cleavable Linkers: Enhancing Stability and Therapeutic Efficacy in Antibody-Drug Conjugates

Tomohiro Watanabe, Tomohiro Fujii and Yutaka Matsuda

J. Synth. Org. Chem. Jpn., 2024, 82, 1117
DOI: 10.5059/yukigoseikyokaishi.82.1117

Dual-payload antibody–drug conjugates: Taking a dual shot

Junjie Tao, Yilin Gu, Wei Zhou and Yuxi Wang

European Journal of Medicinal Chemistry, 2025, 281, 116995
DOI: 10.1016/j.ejmech.2024.116995

General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody–Drug Conjugates

Xiao Zhang, Chong Ou, Huiying Liu, Sunaina Kiran Prabhu, Chao Li, Qiang Yang and Lai-Xi Wang

ACS Chem. Biol., 2021, 16, 2502
DOI: 10.1021/acschembio.1c00597

eSOMA-DM1, a Maytansinoid-Based Theranostic Small-Molecule Drug Conjugate for Neuroendocrine Tumors

Dylan Chapeau, Savanne Beekman, Amber Piet, Le Li, Corrina de Ridder, Debra Stuurman and Yann Seimbille

Bioconjugate Chem., 2024, 35, 1823
DOI: 10.1021/acs.bioconjchem.4c00413

Branched Linkers for Homogeneous Antibody-Drug Conjugates: How Long Is Long Enough?

Evgeny L. Gulyak, Olga A. Komarova, Yury A. Prokopenko, Elina A. Faizullina, Diana M. Malabuiok, Aigul R. Ibragimova, Yuliana A. Mokrushina, Oxana V. Serova, Galina P. Popova, Mikhail Y. Zhitlov, Timofei D. Nikitin, Vladimir A. Brylev, Alexey V. Ustinov, Vera A. Alferova, Vladimir A. Korshun, Ivan V. Smirnov, Stanislav S. Terekhov and Ksenia A. Sapozhnikova

IJMS, 2024, 25, 13356
DOI: 10.3390/ijms252413356

Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody–Drug Conjugates

Tomohiro Watanabe, Naoko Arashida, Tomohiro Fujii, Natsuki Shikida, Kenichiro Ito, Kazutaka Shimbo, Takuya Seki, Yusuke Iwai, Ryusuke Hirama, Noriko Hatada, Akira Nakayama, Tatsuya Okuzumi and Yutaka Matsuda

J. Med. Chem., 2024, 67, 18124
DOI: 10.1021/acs.jmedchem.4c01251

The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates

Seungmin Han, Kwang Suk Lim, Brody J. Blackburn, Jina Yun, Charles W. Putnam, David A. Bull and Young-Wook Won

Pharmaceutics, 2022, 14, 1707
DOI: 10.3390/pharmaceutics14081707

Antibody-drug conjugates in solid tumors; new strategy for cancer therapy

Toshiaki Takakura, Toshio Shimizu and Nobuyuki Yamamoto

Japanese Journal of Clinical Oncology, 2024, 54, 837
DOI: 10.1093/jjco/hyae054

An immunomodulatory polypeptide hydrogel for osteochondral defect repair

Meng Yang, Zheng-Chu Zhang, Fu-Zhen Yuan, Rong-Hui Deng, Xin Yan, Feng-Biao Mao, You-Rong Chen, Hua Lu and Jia-Kuo Yu

Bioactive Materials, 2023, 19, 678
DOI: 10.1016/j.bioactmat.2022.05.008

The role of hydrophilic linkers in next-generation antibody-drug conjugates

Qiang Fu, Xueqing Kong, Yisong Liu, Meitong Liu, Kun Huang, Peng George Wang and Kui Wu

Journal of Controlled Release, 2026, 391, 114612
DOI: 10.1016/j.jconrel.2026.114612

Advanced Synthesis, Structural Characterization, and Functional Applications of Precision Polymers

Jie Cen, Mingxuan Hou, Jinming Hu and Shiyong Liu

Chemistry A European J, 2024, 30
DOI: 10.1002/chem.202401911

Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics

Ruipeng Mu, Jiaqi Yuan, Yue Huang, John K. Meissen, Si Mou, Meina Liang and Anton I. Rosenbaum

BioDrugs, 2022, 36, 181
DOI: 10.1007/s40259-022-00518-w

Recent progress on polySarcosine as an alternative to PEGylation: Synthesis and biomedical applications

Mohamed Fawzi Kabil, Hassan Mohamed El-Said Azzazy and Maha Nasr

International Journal of Pharmaceutics, 2024, 653, 123871
DOI: 10.1016/j.ijpharm.2024.123871

TfR1-Binding Peptide Conjugation Facilitates Robust and Specific siRNA Delivery to the Central Nervous System

Tiancheng Fu, Fushun Fan, Yingying Lin, Zhenxian Mo, Minhua Zhou, Xiaolan Ye, Xiong Cai, Zaijun Zhang, Changgeng Qian and Xinjian Liu

Bioconjugate Chem., 2025, 36, 1377
DOI: 10.1021/acs.bioconjchem.5c00225

Therapeutic peptides and proteins: Status and developments in drug delivery

Braxten D. Hornsby, Cheng Hua Lee, Cassidy A. Steele, Julius K.K. Tuekpe and Carol S. Lim

Journal of Controlled Release, 2026, 394, 114895
DOI: 10.1016/j.jconrel.2026.114895

Synthesis and characterization of bisalkylated polysarcosine-based lipopolymers

Christian Muhl, Marcus Conrad, Dennis Unthan and Matthias Barz

European Polymer Journal, 2019, 120, 109223
DOI: 10.1016/j.eurpolymj.2019.109223

ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors

Marc Lopez, Emerence Crompot, Emmanuelle Josselin, Anne Farina, Marion Rubis, Remy Castellano, Joanna Fares, Maria Wehbe, Yves Collette, Emmanuelle Charafe, Stéphanie Blanchin, François Romagne, Anikó Pálfi, Torsten Hechler, Andreas Pahl, Hatem A. Azim, Florence Lhospice, Emilie Mamessier, François Bertucci, Jack Elands, Xavier Préville and Daniel Olive

Cancer Research Communications, 2024, 4, 2998
DOI: 10.1158/2767-9764.CRC-24-0176

Recent Advances in Peptide Linkers of Antibody–Drug Conjugates

Lu Yang, Jiahui Ma, Ben Liu, Yangbing Li, Yaping Ma, Hao Chen and Zhijian Han

J. Med. Chem., 2025, 68, 18099
DOI: 10.1021/acs.jmedchem.5c01500

Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates

Prathap Kumar Mahalingaiah, Rita Ciurlionis, Kenneth R. Durbin, Ronnie L. Yeager, Binu K. Philip, Bhupinder Bawa, Srinivasa R. Mantena, Brian P. Enright, Michael J. Liguori and Terry R. Van Vleet

Pharmacology & Therapeutics, 2019, 200, 110
DOI: 10.1016/j.pharmthera.2019.04.008

Safe and Efficient Intracellular Release of SN38 via Lysosomal-Responsive SN38-G Loaded Liposomes

Pierre-Alain Burnouf, Yu-Cheng Su and Shih-Hung Yang

ACS Appl. Bio Mater., 2025, 8, 6231
DOI: 10.1021/acsabm.5c00722

Exploring the next generation of antibody–drug conjugates

Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha and Chisato M. Yamazaki

Nat Rev Clin Oncol, 2024, 21, 203
DOI: 10.1038/s41571-023-00850-2

Next-generation Antibody-drug Conjugates (ADCs): Exploring New Frontiers with Chemical Approaches

Yasuaki Anami and Kyoji Tsuchikama

J. Synth. Org. Chem. Jpn., 2020, 78, 503
DOI: 10.5059/yukigoseikyokaishi.78.503

Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines

Ariana Abawi, Xiaoyi Wang, Julien Bompard, Anna Bérot, Valentina Andretto, Leslie Gudimard, Chloé Devillard, Emma Petiot, Benoit Joseph, Giovanna Lollo, Thierry Granjon, Agnès Girard-Egrot and Ofelia Maniti

IJMS, 2021, 22, 4103
DOI: 10.3390/ijms22084103

Emerging targeted drug delivery strategies toward ovarian cancer

Zhe Wang, Fenghua Meng and Zhiyuan Zhong

Advanced Drug Delivery Reviews, 2021, 178, 113969
DOI: 10.1016/j.addr.2021.113969

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Jinhua Chen, Nicholas Corr, Josefa dela Cruz-Chuh, Geoffrey Del Rosario, Aaron Fullerton, Steven J. Hartman, Fan Jiang, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liling Liu, Ying Lu, Melinda M. Mulvihill, Jeremy M. Murray, Aimee O’Donohue, Rebecca K. Rowntree, William S. Sawyer, Leanna R. Staben, John Wai, Jian Wang, BinQing Wei, Wentao Wei, Zijin Xu, Hui Yao, Shang-Fan Yu, Donglu Zhang, Hongyan Zhang, Shenhua Zhang, Yongxin Zhao, Hao Zhou and Xiaoyu Zhu

J. Med. Chem., 2021, 64, 2576
DOI: 10.1021/acs.jmedchem.0c01846

In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy

Rémi Châtre, Justin Lange, Elodie Péraudeau, Pauline Poinot, Stéphanie Lerondel, Alain Le Pape, Jonathan Clarhaut, Brigitte Renoux and Sébastien Papot

Journal of Controlled Release, 2020, 327, 19
DOI: 10.1016/j.jconrel.2020.08.008

Payload diversification: a key step in the development of antibody–drug conjugates

Louise Conilh, Lenka Sadilkova, Warren Viricel and Charles Dumontet

J Hematol Oncol, 2023, 16
DOI: 10.1186/s13045-022-01397-y

Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry

Tomohiro Fujii and Yutaka Matsuda

Expert Opinion on Biological Therapy, 2023, 23, 1053
DOI: 10.1080/14712598.2023.2276873

Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology

Clara Esnault, David Schrama, Roland Houben, Serge Guyétant, Audrey Desgranges, Camille Martin, Patricia Berthon, Marie-Claude Viaud-Massuard, Antoine Touzé, Thibault Kervarrec and Mahtab Samimi

Cancers, 2022, 14, 778
DOI: 10.3390/cancers14030778

A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future

Emily Holz, Martine Darwish, Devin B. Tesar and Whitney Shatz-Binder

Pharmaceutics, 2023, 15, 600
DOI: 10.3390/pharmaceutics15020600

Transmembrane signaling by a synthetic receptor in artificial cells

Ane Bretschneider Søgaard, Andreas Bøtker Pedersen, Kaja Borup Løvschall, Pere Monge, Josefine Hammer Jakobsen, Leila Džabbarova, Line Friis Nielsen, Sandra Stevanovic, Raoul Walther and Alexander N. Zelikin

Nat Commun, 2023, 14
DOI: 10.1038/s41467-023-37393-0

Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies

Yutaka Matsuda, Jenny R. Chang and Brian A. Mendelsohn

ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202500305

Poly(ethylene glycol) alternatives in biomedical applications

Xikuang Yao, Chao Qi, Changrui Sun, Fengwei Huo and Xiqun Jiang

Nano Today, 2023, 48, 101738
DOI: 10.1016/j.nantod.2022.101738

Optimization of a pendant-shaped PEGylated linker for antibody-drug conjugates

T. Tedeschini, B. Campara, A. Grigoletto, I. Zanotto, L. Cannella, D. Gabbia, Y. Matsuno, A. Suzuki, H. Yoshioka, A. Armirotti, S. De Martin and G. Pasut

Journal of Controlled Release, 2024, 375, 74
DOI: 10.1016/j.jconrel.2024.08.049

In vivo safety testing of Antibody Drug Conjugates

Francesca Pretto and Rex E. FitzGerald

Regulatory Toxicology and Pharmacology, 2021, 122, 104890
DOI: 10.1016/j.yrtph.2021.104890

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform

Louise Conilh, Guy Fournet, Eric Fourmaux, Angélique Murcia, Eva-Laure Matera, Benoît Joseph, Charles Dumontet and Warren Viricel

Pharmaceuticals, 2021, 14, 247
DOI: 10.3390/ph14030247

Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice

Ling Zhou, Yunlong Lu, Wei Liu, Shanglong Wang, Lingling Wang, Pengdou Zheng, Guisha Zi, Huiguo Liu, Wukun Liu and Shuang Wei

Exp Hematol Oncol, 2024, 13
DOI: 10.1186/s40164-024-00493-8

GD2-Targeted Minibody–Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model

Daniel V. Kalinovsky, Matvey M. Titov, Irina V. Kholodenko, Alexey V. Kibardin, Elena V. Svirshchevskaya, Sergey M. Deyev and Roman V. Kholodenko

IJMS, 2026, 27, 1974
DOI: 10.3390/ijms27041974

Methods for the Generation of Single‐Payload Antibody‐Drug Conjugates

Thomas Wharton and David R. Spring

ChemMedChem, 2025, 20
DOI: 10.1002/cmdc.202500132

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties

Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Sunil Bhakta, Nicole Blaquiere, Jinhua Chen, Josefa dela Cruz-Chuh, Karen E. Gascoigne, Steven J. Hartman, Mingtao He, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liang Liu, Liling Liu, Qi Liu, Ying Lu, Fanwei Meng, Melinda M. Mulvihill, Aimee O’Donohue, Rebecca K. Rowntree, Leanna R. Staben, Steven T. Staben, John Wai, Jian Wang, BinQing Wei, Catherine Wilson, Jianfeng Xin, Zijin Xu, Hui Yao, Donglu Zhang, Hongyan Zhang, Hao Zhou and Xiaoyu Zhu

J. Med. Chem., 2021, 64, 2534
DOI: 10.1021/acs.jmedchem.0c01845

From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation

Imsha Parveen, Anjlina Aqil, Sumit Sharma, Abdul Qadir, Sayed Abdur Rehman, Ashif Iqubal, Khang Wen Goh, Rajath Govind, Mohammad Kashif Iqubal and Prashant Kesharwani

Journal of Drug Delivery Science and Technology, 2026, 120, 108271
DOI: 10.1016/j.jddst.2026.108271

29th Annual GP2A Medicinal Chemistry Conference

Jean-Jacques Helesbeux, Laura Carro, Florence O. McCarthy, Vânia M. Moreira, Francesca Giuntini, Niamh O’Boyle, Susan E. Matthews, Gülşah Bayraktar, Samuel Bertrand, Christophe Rochais and Pascal Marchand

Pharmaceuticals, 2021, 14, 1278
DOI: 10.3390/ph14121278

Sequence-Defined Synthetic Polymers for New-Generation Functional Biomaterials

Zhengyu Deng, Qiangqiang Shi, Jiajia Tan, Jinming Hu and Shiyong Liu

ACS Materials Lett., 2021, 3, 1339
DOI: 10.1021/acsmaterialslett.1c00358

Highway to Success—Developing Advanced Polymer Therapeutics

Marianne B. Ashford, Richard M. England and Nadim Akhtar

Advanced Therapeutics, 2021, 4
DOI: 10.1002/adtp.202000285

Antibody–drug conjugates: prospects for the next generation

Meriem Grairi and Marc Le Borgne

Drug Discovery Today, 2024, 29, 104241
DOI: 10.1016/j.drudis.2024.104241

Homogeneous multi-payload antibody–drug conjugates

Toby Journeaux and Gonçalo J. L. Bernardes

Nat. Chem., 2024, 16, 854
DOI: 10.1038/s41557-024-01507-y

A Versatile Platform to Generate Prodrugs with Rapid and Precise Albumin Hitchhiking and High Cargo Loading for Tumor‐Targeted Chemotherapy

Jing Li, Huimin Xing, Jie Chen, Hongyu Lu, Ze Tao, Yiran Tao, Yunqing Sun, Tao Su, Xin Li, Huansheng Chang, Shiyuan Chen, Zhuo Chen, Hao Yang, Jingqiu Cheng, Hong Zhu and Xiaofeng Lu

Small, 2024, 20
DOI: 10.1002/smll.202304253

Polypept(o)ides – Origins, synthesis, applications and future directions

Tobias Alexander Bauer, Leon Simić, Joachim F.R. Van Guyse, Aroa Duro-Castaño, Vicent J. Nebot and Matthias Barz

Progress in Polymer Science, 2024, 158, 101889
DOI: 10.1016/j.progpolymsci.2024.101889

Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs

Brittney J. Mills, Terra Kruger, Milan Bruncko, Xinxin Zhang and Feroz Jameel

Journal of Pharmaceutical Sciences, 2020, 109, 1662
DOI: 10.1016/j.xphs.2020.01.029

LILRB4-targeting Antibody–Drug Conjugates for the Treatment of Acute Myeloid Leukemia

Yasuaki Anami, Mi Deng, Xun Gui, Aiko Yamaguchi, Chisato M. Yamazaki, Ningyan Zhang, Cheng Cheng Zhang, Zhiqiang An and Kyoji Tsuchikama

Molecular Cancer Therapeutics, 2020, 19, 2330
DOI: 10.1158/1535-7163.MCT-20-0407

Exo-Linker: Unlocking Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates

Tomohiro Watanabe and Tomohiro Fujii

DDS, 2025, 40, 385
DOI: 10.2745/dds.40.385

Sequence-defined polymers for biomedical applications

Nicholas Jäck, Sören Nagel and Laura Hartmann

Progress in Polymer Science, 2025, 167, 101993
DOI: 10.1016/j.progpolymsci.2025.101993

Antibody Conjugates-Recent Advances and Future Innovations

Donmienne Leung, Jacqueline Wurst, Tao Liu, Ruben Martinez, Amita Datta-Mannan and Yiqing Feng

Antibodies, 2020, 9, 2
DOI: 10.3390/antib9010002

More than Toxins—Current Prospects in Designing the Next Generation of Antibody Drug Conjugates

Jonathan Schwach, Mustafa Abdellatif and Andreas Stengl

Front. Biosci. (Landmark Ed), 2022, 27
DOI: 10.31083/j.fbl2708240

Antibody–drug conjugates: Recent advances in linker chemistry

Zheng Su, Dian Xiao, Fei Xie, Lianqi Liu, Yanming Wang, Shiyong Fan, Xinbo Zhou and Song Li

Acta Pharmaceutica Sinica B, 2021, 11, 3889
DOI: 10.1016/j.apsb.2021.03.042

Recent Advances in Peptide Linkers for Antibody-Drug Conjugates

Shaoting Li, Yu Guo, Jinxin Che, Haibin Dai and Xiaowu Dong

J. Med. Chem., 2025, 68, 19871
DOI: 10.1021/acs.jmedchem.5c01982

Preclinical Characterization of XB010: A Novel Antibody–Drug Conjugate for the Treatment of Solid Tumors that Targets Tumor-Associated Antigen 5T4

Brian A. Mendelsohn, Kathleen R. Gogas, Jeffrey N. Higaki, Willy A. Solis, Inna Vainshtein, Jackie Cheng, Minjong Park, Marlene A. Hennessy, Christine M. Janson, Yutaka Matsuda, Robyn M. Barfield, Penelope M. Drake, Stepan Chuprakov, Colin L. Hickle, Tom Linz, Maxine Bauzon, Dominick Y. Yeo, Fangjiu Zhang, Ayodele O. Ogunkoya and Seema Kantak

Molecular Cancer Therapeutics, 2025, 24, 1856
DOI: 10.1158/1535-7163.MCT-24-1014